서비스 > Custom Synthesis

Peptide synthesis

- GMP Grade Peptides
- Cosmetic Peptides
- Pharmaceutical Peptides
고품질 맞춤형 펩타이드(high quality custom peptides), 수백 가지의 modification 펩타이드, 펩타이드 라이브러리(peptide library)등을 포함한 광범위한 펩타이드 서비스를 완벽히 구축된 프로토콜을 이용하여 합성하고 QA / QC 를 통해 검증된 펩타이드만을 제공하고 있습니다.

10년 이상의 peptide 합성 경험, 95%이상의 성공율
GMP 등급 생산가능
Peptide 길이 짧은 길이부터 100 amino acids 이상의 긴 길이도 합성 가능
Modifications available Modified amino acids, labels, N- and C-terminal conjugation 등 합성 가능
합성 가능한 용량 mg 단위부터 kg 단위까지
무료 서비스 Solubility Testing과 TFA 제거는 요청시 무료로 진행
제공 데이터 HPLC 및 MS 데이터 제공, 추가 QC 데이터는 요청시 제공

Chemically Modificationed siRNA
Modification Type
{H-},Free amino group
{Ac},Acetylation
{Br-Ac},Bromoacetyl
{Bromopropionyl}
{Cl-Ac},Chloroacetyl
{Fmoc},9-Fluorenylmethyloxycarbonyl
{Z},{CBZ},Benzyloxycarbonyl
{Bz},benzoyl
{4-F-Bz}
{Cl-Ac},Chloroacetyl
{Boc},tertbutoxycarbonyl
{Suc},succinyl
{MeO-Suc}
Sebacic acid
{Allyl},allyl
{Acryl},acryl
{Alloc},allyloxycarbonyl
{For}, Formylation
{HPP},4-Hydroxyphenylpropionic acid
{pGlu},{Pyr},Pyroglutamyl
{LA}, Lipoic acid
{Mpa},3-Mercaptopropyl
{6-mercaptohexanoic acid}
{Mal}, Maleimide, Maleoyl-b-Ala
Mal-Acp
{MTX}, Methotrexate
{PEG1900}, PEG1900-NH-
{NH2-PEG2000}, NH2-PEG2000-NH-Suc-
{mPEG2000}, MeO-PEG2000-NH-
{mPEG3000}, MeO-PEG3000-NH-
{mPEG5000}, MeO-PEG5000-NH-
{SATA}, S-acetylthioacetate
{SATP}, S-acetylthiopropionate
{Cholesteryl-}, Cholesteryl chloroformate
{Glucose-}
{Fructose-}
Pyridin-1-yl-Acetyl-
4-Dimethylamino-Pyridin-1-yl-
Adamantanecarbonyl-
Phenylacetic acid
4-Biphenyl sulfonyl-
Nitrilotriacetyl-
N-Propargylglycine-
HYNIC-
Morpholine-4-carbonyl-
5-amino-2-nitrobenzonic acid
Azido-PEG4-
GAC-
{Aoa}
N3-Gly
N3-Acp
Modification Type
{But}, Butyric acid C4
{Iba}, isobutyric acid C4
{Hex}, Hexanoic acid C6
{Oct}, Octanoic acid C8
{F-Oct}, Perfluoro Octanoic acid F15C8
{Dec}, Decanoic acid C10
{F-Dec}, Perfluoro Decanoic acid F19C10
{Lau}, Lauric acid C12
{F-Lau}, Perfluoro Lauric acid F23C12
{Myr}, Myristic acid C14
{F-Myr}, Perfluoro Myristic acid F27C14
{Pal}, Palmitic acid C16
{Ste}, Stearic acid C18
{Ste}, Stearic acid C18
Oleic Acid-
{Pam3C}, Tripalmitoyl cysteine, {Pal-Cys(Pal)2-}
Modification Type
{-OH}, free acid group
{NH2}, Amidation
{-CHO}, peptide aldehydes
{-ol}, alcohol peptide
{CMK}, chloromethylketone
{FMK}, Fluoromethylketone
{Cya}, Cysteamide
{pNA},p-nitroaniline
{-ONP}, para-nitrophenol
{AMC},7-Amino-4-methylcoumarin
{AFC}
-OMe (C-terminal)
-OEt (C-terminal)
-OBzl (C-terminal)
-OtBu (C-terminal)
{-OSu}, hydroxysucinimide ester
-NHMe (C-terminal)
-NHEt (C-terminal)
-NHisopen (C-terminal)
-NH(CH2)6 (C-terminal)
-NHPh (C-terminal)
{NHEt(O)EtNH-Fmoc}, 2,2'-Oxydi Ethanamine-Fmoc
{NHEt(EtNH-Myr)2}
-NH(OMe)Me (C-terminal)
-TBzl (C-terminal)
-NHNH2 (C-terminal)
-ED (C-terminal), -NH-CH2CH2-NH2
-BD (C-terminal), -NH-CH2CH2CH2CH2-NH2
-Pyrenemethylamine
chloro-4-hydroxyanilide
4-amino-2-Chlorophenol
-octyl ester
-ED-Fmoc
Modification Type
{D-Ala}
{D-Arg}
{D-Asp}
{D-Asn}
{D-Cys}
{D-Glu}
{D-Gln}
{D-Glu}
{D-His}
{D-Allo-Ile}
{D-Leu}
{D-Lys}
{D-Met}
{D-Pro}
{D-Phe}
{D-Ser}
{D-Tyr}
{D-Thr}
{D-Trp}
{D-Val}
Modification Type
{Beta-Asp}
{D-Beta-Asp}
{Gamma-Glu}
{D-Gamma-Glu}
{Cys(Cam)}
{Cys(Acm)}
{Cys(tBu)}
{Met(O)}
{D-Met(O)}
{Met(O)2}
{D-Met(O)2}
{Lys(Ac)}
{Ac-Lys}
{Lys(Dde)}
{Tle}
{Ser(octanoic acid)}
{D-Ser(octanoic acid)}
{Aib}
{Abu}
{D-Abu}
{Hyp}
{Phg}
{D-Phg}
{Nva}
{D-Nva}
{Nle}
{D-Nle}
{Cit}
{D-Cit}
{Orn}
{D-Orn}
{Pen}
{D-Pen}
{Cpg}, cyclopentylglycine
{Cha}
{D-Cha}
{Chg}
{D-Chg}
{Dab}
{Dap}
{Pra}
{D-Pra}
{Gly(allyl)}
{D-Gly(allyl)}
{D-1-Nal}
{L-1-Nal}
{D-2-Nal}
{L-2-Nal}
{D-2-Pal}
{L-2-Pal}
{D-3-Pal}
{L-3-Pal}
{D-4-Pal}
{L-4-Pal}
{Cys(pMeBzl)}
{Cys(pMeOBzl)}
{Oic}
{Tic}
{Cys(Bzl)}
{Epsilon-Lys}
{D-Epsilon-Lys}
{5-ASA}
{Bpa}
{Pip}
{Nip}
{2-Aze}
{3-Aze}
[Psi(CH2NH)]
[CS-NH]
{Se-Met}
{Se-Cys}
{DOPA}
{isoGln}
{D-isoGln}
Cys(Mal-PEG2000)
{Ser(O-b-D-Glc)}
{Thr(O-b-D-Glc)}
{Tyr(O-b-D-Glc)}
{Rink Linker}
{Thr(OAc)}
{Delta-Orn}
{5,5-Dime-Pro}
{Gla}
{Kep}
{X}, 20 Kinds mixture amino acids
{X-deCys}
{G/A/S/V/L/D/K/M/F/Y}
{A/P/T/N/Q/E/H/R/W}
{K(75)X(25)}
{R(25)K(25)X(50)}
{E(25)D(25)X(50)}
{K(25)Q(25)X(50)}
{E(25)T(25)X(50)}
Modification Type
Biotin (N-Terminal)
EDBiotin (C terminus)
Lys(Biotin) (middle)
Lys(Biotin) (C temrinus)
Lys(Biotin) (N terminus)
Biotin-LC (N-Terminal)
Lys(LC-Biotin) (middle)
Lys(LC-Biotin) (C terminus)
Orn(Bio)
-NH-PEG3-Bio
FITC (N-Terminal)
EDFITC (C temrinus)
Lys(FITC) (middle)
Lys(FITC) (C temrinus)
Lys(FITC) (N terminus)
FITC-LC (N-Terminal)
5-FAM (N-Terminal)
ED5-FAM (C temrinus)
Lys(5-FAM) (middle)
Lys(5,6-FAM)
Lys(5-FAM) (C temrinus)
Lys(5-FAM) (N-Terminus)
5-FAM-LC (N-Terminal)
Dansyl (N-Terminal)
EDDansyl (C temrinus)
Lys(Dansyl) (middle)
Lys(Dansyl) (C temrinus)
Lys(Dansyl) (N-Terminus)
Dansyl-LC (N-Terminal)
TAMRA (N-Terminal)
5(6)-TAMTA-
EDTAMRA (C temrinus)
Lys(TAMRA) (middle)
Lys(TAMRA) (C temrinus)
Lys(TAMRA) (N-terminus)
TAMRA-LC (N-Terminal)
Lys(Dnp) (middle)
D-Lys(Dnp) (middle)
Dab(Dnp) (middle)
Dap(Dnp) (middle)
EDDnp (C terminus)
MCA (N-Terminal)
Lys(MCA) (middle)
Lys(MCA) (C temrinus)
Lys(MCA) (N-terminus)
3-Indolylacetic acid (N-Terminal)
Cys(Npys) (N-terminus)
PyBA- (N-Terminal), 1-pyrenebutyric acid
Lys(PyBA)
Fa- (N-Terminal), 3-[2-2furyl]acrylic acid
Rhodamine B- (N-Terminal)
D-Luciferin (N-terminus)
Cy3- (N-Terminal)
NBD
Modification Type
{D-2-Cl-Phe}
{L-2-Cl-Phe}
{D-3-Cl-Phe}
{L-3-Cl-Phe}
{D-4-Cl-Phe}
{L-4-Cl-Phe}
{D-3,4-DiCl-Phe}
{L-3,4-DiCl-Phe}
{D-4-Br-Phe}
{L-4-Br-Phe}
{D-3-F-Phe}
{L-3-F-Phe}
{D-4-F-Phe}
{L-4-F-Phe}
{D-4-NO2-Phe}
{L-4-NO2-Phe}
{D-4-I-Phe}
{L-4-I-Phe}
{D-3-CN-Phe}
{L-3-CN-Phe}
{D-4-CN-Phe}
{L-4-CN-Phe}
{D-2-Me-Phe}
{L-2-Me-Phe}
{D-4-Me-Phe}
{L-4-Me-Phe}
{D-4-NH2-Phe}
{L-4-NH2-Phe}
{D-3-Cl-Tyr}
{L-3-Cl-Tyr}
{D-3,5-DiCl-Tyr}
{L-3,5-DiCl-Tyr}
{D-3,5-DiBr-Tyr}
{L-3,5-DiBr-Tyr}
{D-3-I-Tyr}
{L-3-I-Tyr}
{D-3,5-DiI-Tyr}
{L-3,5-DiI-Tyr}
{D-3-NO2-Tyr}
{L-3-NO2-Tyr}
{D-3,5-DiNO2-Tyr}
{L-3,5-DiNO2-Tyr}
{L-3-F-Tyr}
Modification Type
{Har}, HomoArg
{Hcy}, HomoCys
{HPh}, HomoPhe
{D-HPh}, D-HomoPhe
{Hse}, HomoSer
{D-Hse}, D-HomoSer
{HomoCit}, HomoCit
{D-HomoCit}, D-HomoCit
{HomoLeu}, HomoLeu
{HomoPro}, HomoPro
{D-HomoPro}, D-HomoPro
{beta-HomoIle}, beta-HomoIle
{beta-HomoLeu}, beta-HomoLeu
{beta-HomoMet}, beta-HomoMet
{beta-HomoPro}, beta-HomoPro
{beta-HomoVal}, beta-HomoVal
{beta-HomoAsp}, beta-HomoAsp
{beta-HomoAsn}, beta-HomoAsn
{beta-HomoGlu}, beta-HomoGlu
{beta-HomoGln}, beta-HomoGln
{beta-HomoSer}, beta-HomoSer
{beta-HomoThr}, beta-HomoThr
{beta-HomoTrp}, beta-HomoTrp
{beta-HomoTyr}, beta-HomoTyr
{Azidohomoalanine}, Azidohomoalanine
{beta-HomoAla}, beta-HomoAla
{beta-HomoPhe}, beta-HomoPhe
{beta-HomoLys}, beta-HomoLys
Modification Type
Abz
Tyr (3-NO2)
Glu(EDANS)-NH2
DABCYL
Lys(DABCYL)
Lys(Abz)
Modification Type
Symmetric 2 Branches (Pure)
Orn Symmetric 2 Branches (Pure)
Symmetric 4 Branches (Crude)
Orn Symmetric 4 Branches (Crude)
Symmetric 8 Branches (Crude)
Orn Symmetric 8 Branches (Crude)
Glu 2 Branches (N temrinus)
Glycerol 3 branches (C terminus)
Lys(Ala)
Lys(Arg)
Lys(Asp)
Lys(Cys)
Lys(Glu)
Lys(Leu)
Lys(Met)-
Lys(Phe)-
Lys(Val)
Lys(Beta-Asp)
Lys(Gama-Glu)
Lys(Cholesteryl)
Lys(LA)
Lys(MTX)
Lys(Maleimide)
Lys(Mpa)
Lys(Pra)
Lys(Suc)
Lys(pGlu)
Lys(For)
Lys(Ma)
Lys(Pal)
Lys(Gama-Glu-Pal)
Lys(4-HBA)
Lys(Acrylic)
Lys(Alkine)
{Lys(Alloc)}
{Lys(Butanoyl)}
Lys(cyclopropanecarboxyl)
Lys(Crotonyl)
{Lys(3,5-diiodo-4-hydroxybenzoyl)}
Lys(HMP)
{Lys(Ahx-Diazirine)}
{Lys(propargyl)}
{Lys(propionyl)}
Lys(2-hydroxyisobutyryl)
Lys(methylmalony)
Lys(HYNIC)
BSA-Peptide Cys
KLH-Peptide Cys
OVA-Peptide Cys
Modification Type
{Gly}, 2 atoms
{Beta-Ala}, 3 atoms
{GABA}, 4 atoms
{Ava}, 5 atoms
{Ahx}, 6 atoms
{8-Aoc}
{AEA},aminoethoxyacetic acid
{Mini-PEG}, AEEA 9 atoms
{Mini-PEG2}, AEEEP 13 atoms
{Mini-PEG3},AEEEEP 16 atoms
{PEG4}
{PEG6}
{PEG8}
{PEG11}
{PEG-12}
{Ado}
{ANP Linker}
Modification Type
{Arg(Me)}
{ADMA},{Arg(Me)2} asymmetrical
{SDMA},{Arg(Me)2} symmetrical
{Tyr(Me)}
{Thr(Me)}
{Ser(Me)}
{Cys(Me)}, SMC
{Lys(Me)}
{Lys(Me2)}
{Lys(Me3)}
{L-2-Me-Trp}
{D-2-Me-Trp}
{Tyr(Et)}
{D-Tyr(Et)}
{Orn(Me)3}
{L-1-Me-Trp}
Modification Type
{N-Me-Ala}
{N-Me-Phe}
{N-Me-Leu}
{N-Me-Ile}
{N-Me-Val}
{N-Me-Met}
{N-Me-Nle}
{N-Me-Nva}
{N-Me-Gly}, Sar
{N-Me-Ser}
{N-Me-Tyr}
{N-Me-Thr}
{N-Me-Asp}
{N-Me-Glu}
Modification Type
Mono Disulfide bridge
Double Disulfide bridge
Triple Disulfide bridge
Random Triple Disulfide bridge
Same Seq. Inter-Disulfide bridge
Different Inter-Disulfide bridge
Amide cyclic (end)
Amide cyclic (Side chain)
Orn side chain Amide cyclic
Thioester cyclic
Lactone cyclic
Modification Type
{pSer}
{pTyr}
{pThr}
{D-pSer}
{D-pTyr}
{D-pThr}
Di-sites in sequence
Tri-sites in sequence
4-sites in sequence
5-sites in sequence

* resource from BBI website

정제 종류 및 peptide 합성 권장 applications
Crude : 민감하지 않은 screening assay에 사용
>70% : 민감하지 않은 screening assay, 탐색 또는 관련 MS검사
>80% : non quantitative binding assays, ELISPOT assays, polyclonal antibody production
>90% : polyclonal antibody production을 위한 post-translationally modified peptides, receptor-ligand assays
>95% : Quantitative Mass Spectrometry SRM/MRM assays, monoclonal antibodies, quantitative receptor-ligand assays, enzyme kinetics, cell/tissue culture, phosphorylation 연구
>98% : NMR, X-ray structural 연구

Conventional peptide synthesis(5-30aa)
Project description
content 2 mg 5 mg 10 mg 15 mg 20 mg 25 mg
Price
(per AA)
Crude 5,220 5,760 8,560 8,750 9,300 10,050
Desalination 6,300 7,560 10,790 10,980 11,720 12,470
>75% 9,750 11,260 17,120 18,420 21,580 23,630
>85% 12,960 14,420 21,770 25,490 28,460 30,320
>90% 14,580 17,340 24,000 30,320 33,110 34,970
>95% 15,920 17,940 25,300 33,110 37,580 41,110
>98% 22,620 26,990 37,950 49,850 56,550 61,380
Project description
content 30 mg 40 mg 50 mg 60 mg 80 ~ 100 mg 1000 mg
Price
(per AA)
Crude 10,790 12,090 12,650 14,700 15,440 55,060
Desalination 12,840 14,330 14,700 17,120 17,670 57,480
>75% 25,490 26,040 29,950 34,970 41,300 124,250
>85% 31,810 33,670 36,830 41,300 49,480 148,620
>90% 38,320 40,370 43,530 49,480 59,520 178,560
>95% 43,710 46,320 49,480 56,360 66,220 198,280
>98% 65,480 69,940 74,220 84,260 99,330 297,600

*더 긴 peptide 합성이나 modification peptide는 학술지원팀(02-9625-1625)에 문의 바랍니다.